Biography:
Andrew Bevan holds a master’s degree by research in Pharmacology form the University of Dundee (UK) and is a Chartered Scientist. His career in clinical research spans more than 20 years and he is currently Executive Director of Integrated Project Solutions at PPD part of Thermo Fisher Scientific. He has coauthored more than 20 publications and abstracts on a variety of topical areas of interest in clinical research.
Use of a large real world dataset to define representative US populations for phase 3 obesity studies